Page last updated: 2024-11-03

proxymetacaine and Lacrimal Duct Obstruction

proxymetacaine has been researched along with Lacrimal Duct Obstruction in 1 studies

proxymetacaine: RN given refers to parent cpd; structure

Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hung, CH1
Chen, YC1
Lin, SL1
Chen, WL1

Other Studies

1 other study available for proxymetacaine and Lacrimal Duct Obstruction

ArticleYear
Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Pediatrics and neonatology, 2015, Volume: 56, Issue:6

    Topics: Age Factors; Ambulatory Surgical Procedures; Anesthetics, Local; Child, Preschool; Dacryocystorhinos

2015